Finepoint Capital LP
- SEC CIK
- 0001608126
- Latest filing
- Aug 13, 2026
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 12, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 38
- −6 vs. Q4 2022
- Portfolio value
- $261.8M
- −$47.5M (−15.4%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | COM | 875,221 | $19.7M | 7.5% | −151,079−14.7% | Reduced | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 283,690 | $18.7M | 7.1% | −51,200−15.3% | Reduced | History |
| ISEEIVERIC bio, Inc. | COM | 723,600 | $17.6M | 6.7% | +16,000+2.3% | Added | History |
| ACADAcadia Pharmaceuticals Inc | COM | 916,353 | $17.2M | 6.6% | −260,477−22.1% | Reduced | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 444,659 | $17.2M | 6.6% | +54,300+13.9% | Added | History |
| SRPTSarepta Therapeutics, Inc. | COM | 122,757 | $16.9M | 6.5% | −8,700−6.6% | Reduced | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 156,072 | $16.7M | 6.4% | +22,036+16.4% | Added | History |
| SAGESage Therapeutics, Inc. | COM | 388,865 | $16.3M | 6.2% | +7,100+1.9% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 1,460,175 | $16.2M | 6.2% | +31,700+2.2% | Added | History |
| PRTAProthena Corp Public Ltd Co | SHS | 331,600 | $16.1M | 6.1% | +8,700+2.7% | Added | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 614,231 | $15.8M | 6.0% | −28,769−4.5% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 413,793 | $14.6M | 5.6% | +11,000+2.7% | Added | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 868,427 | $13.9M | 5.3% | +45,682+5.6% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 846,270 | $13.9M | 5.3% | +131,422+18.4% | Added | History |
| ARVNArvinas, Inc. | COM | 492,300 | $13.4M | 5.1% | +62,700+14.6% | Added | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 539,445 | $13.2M | 5.0% | +22,158+4.3% | Added | History |
| SLDBSolid Biosciences Inc. | COM NEW | 488,857 | $2.32M | 0.9% | +270,295+123.7% | Added | History |
| Ares Acquisition CorporationG33032122 | *W EXP 99/99/999 | 504,706 | $444.1K | 0.2% | 00.0% | Unchanged | – |
| Home Plate Acquisition Corp43734R111 | *W EXP 09/30/202 | 690,000 | $218.7K | 0.1% | 00.0% | Unchanged | – |
| Bridgetown Holdings LtdG1355U121 | *W EXP 09/30/202 | 895,000 | $134.4K | 0.1% | 00.0% | Unchanged | – |
| Ross Acquisition Corp IIG7641C114 | *W EXP 02/01/202 | 439,666 | $115.2K | <0.1% | 00.0% | Unchanged | – |
| Conyers Park III Acqsitn Cor21289P110 | *W EXP 08/12/202 | 571,666 | $114.3K | <0.1% | 00.0% | Unchanged | – |
| Churchill Capital Corp V17144T115 | *W EXP 10/29/202 | 612,000 | $114.3K | <0.1% | 00.0% | Unchanged | – |
| Marblegate Acquisition Corp.56608A113 | *W EXP 08/31/202 | 735,000 | $110.2K | <0.1% | 00.0% | Unchanged | – |
| Ys Biopharma Co LtdG9845F117 | *W EXP 03/15/202 | 489,999 | $76.3K | <0.1% | +489,999 | New | – |
| Churchill Capital Corp VII17144M110 | *W EXP 02/29/202 | 548,000 | $67.1K | <0.1% | 00.0% | Unchanged | – |
| Afternext Healthtech AcquisiG01109126 | *W EXP 99/99/999 | 366,666 | $61.1K | <0.1% | 00.0% | Unchanged | – |
| Zimmer Energy Transition Acq989570114 | *W EXP 06/16/202 | 358,270 | $60.1K | <0.1% | 00.0% | Unchanged | – |
| Jaws Hurricane Acquisitn Cor47201B111 | *W EXP 03/26/202 | 387,249 | $60.1K | <0.1% | 00.0% | Unchanged | – |
| Swiftmerge Acquisition CorpG63836111 | *W EXP 12/13/202 | 490,000 | $59.9K | <0.1% | 00.0% | Unchanged | – |
| Compass Digital Acquisitn CoG2476C123 | *W EXP 09/29/202 | 459,906 | $59.8K | <0.1% | 00.0% | Unchanged | – |
| Churchill Capital Corp VI17143W119 | *W EXP 02/17/202 | 540,000 | $59.4K | <0.1% | 00.0% | Unchanged | – |
| Corsair Partnering CorpG2540H116 | *W EXP 07/06/202 | 334,666 | $53.6K | <0.1% | 00.0% | Unchanged | – |
| Senior Connect Acquisitn Cor81723H116 | *W EXP 12/31/202 | 1,014,000 | $51.3K | <0.1% | 00.0% | Unchanged | – |
| CNDAWConcord Acquisition Corp II | *W EXP 99/99/999 | 408,333 | $28.6K | <0.1% | 00.0% | Unchanged | History |
| CLDWWCalidi Biotherapeutics, Inc. | *W EXP 03/14/202 | 655,200 | $26.9K | <0.1% | 00.0% | Unchanged | History |
| Bilander Acquisition Corp.09001T114 | *W EXP 05/19/202 | 183,749 | $23.9K | <0.1% | 00.0% | Unchanged | – |
| Skydeck Acquisition Corp.G82220115 | *W EXP 05/13/202 | 361,756 | $18.1K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q4 2022 (7)
Positions held at the end of Q4 2022 that are gone from this filing.
| Security | Class | Shares in Q4 2022 | Value in Q4 2022 | % of portfolio in Q4 2022 | History |
|---|---|---|---|---|---|
| ASTLAlgoma Steel Group Inc. | COM | 3,219,441 | $20.4M | 6.6% | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,545,589 | $9.88M | 3.2% | History |
| DISH Network CORP25470MAF6 | NOTE 12/1 | – | $9.64M | 3.1% | – |
| Summit Healthcre Acquistn CoG8566R110 | *W EXP 06/03/202 | 489,999 | $139.0K | <0.1% | – |
| Berenson Acquisition Corp. I083690115 | *W EXP 08/01/202 | 862,499 | $31.0K | <0.1% | – |
| Levere Holdings Corp.G5462L122 | *W EXP 03/09/202 | 274,999 | $4.00K | <0.1% | – |
| Catalyst Partnrs Acquisitn CG19550121 | *W EXP 05/12/202 | 336,666 | $1.00K | <0.1% | – |